Geode Capital Management LLC Has $79.54 Million Position in Bath & Body Works, Inc. $BBWI

Geode Capital Management LLC increased its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 2.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,960,475 shares of the company’s stock after buying an additional 110,602 shares during the quarter. Geode Capital Management LLC’s holdings in Bath & Body Works were worth $79,542,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Royal Bank of Canada boosted its holdings in shares of Bath & Body Works by 92.8% in the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company’s stock valued at $1,815,000 after purchasing an additional 28,815 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after acquiring an additional 87,529 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Bath & Body Works by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company’s stock valued at $17,063,000 after acquiring an additional 36,684 shares during the last quarter. Intech Investment Management LLC bought a new position in Bath & Body Works during the 1st quarter worth $1,155,000. Finally, Geneos Wealth Management Inc. raised its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $17.44 on Monday. The company’s fifty day simple moving average is $18.58 and its two-hundred day simple moving average is $20.07. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $33.96. The stock has a market capitalization of $3.51 billion, a price-to-earnings ratio of 4.90, a PEG ratio of 1.73 and a beta of 1.42.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The business’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Equities research analysts anticipate that Bath & Body Works, Inc. will post 2.62 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.6%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s dividend payout ratio is presently 22.47%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on BBWI. Weiss Ratings lowered Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday, June 2nd. Wells Fargo & Company lowered their price objective on Bath & Body Works from $29.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Telsey Advisory Group lowered their price objective on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a research report on Thursday, May 28th. Citigroup downgraded Bath & Body Works from a “buy” rating to a “neutral” rating and raised their target price for the company from $21.00 to $25.00 in a research note on Tuesday, February 17th. Finally, TD Cowen raised their target price on Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $21.93.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.